Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Experimental Botany|February 20, 2019
An atypical aspartic protease modulates lateral root development in Arabidopsis thalianaAndré Soares, Stefan Niedermaier, Rosário Faro, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Expression and glycoengineering of functionally active heteromultimeric IgM in plantsAndreas Loos, Clemens Gruber, Friedrich Altmann, et al.
Plant Biotechnology Journal|July 1, 2014
Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plantsHuafang Lai, Junyun He, Jonathan Hurtado, et al.
Biotechnology Journal|January 31, 2014
The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platformsMelanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta, et al.
Plant Physiology|February 18, 2011
Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of ArabidopsisAndreas Loos, Bart Van Droogenbroeck, Stefan Hillmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2015
Glycan modulation and sulfoengineering of anti-HIV-1 monoclonal antibody PG9 in plantsAndreas Loos, Johannes S Gach, Thomas Hackl, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.
Plos Pathogens|July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibodyMichael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.
Cell Reports. Medicine|March 2, 2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamstersMichael S Piepenbrink, Jun-Gyu Park, Fatai S Oladunni, et al.
Pageof 2